Based in Belgium and established in 1996, Coris BioConcept is a middle-sized company (SME) specialized in developing, manufacturing and marketing rapid diagnostic kits for the detection of human respiratory and gastro-enteric infectious pathogens (bacteria, viruses and parasites) and for the detection of antibiotic resistance markers (RESIST range). These tests are based on the lateral flow immunochromatography technology with colloidal gold particles or latex microspheres. These rapid tests are extensively used in microbiology laboratories worldwide.
To complement this extensive range of fast and accurate lateral flow tests, the company has developed an innovative automated platform that performs multiplex PCR amplification and detection on a microfluidic cartridge (TRAPIST® system). This molecular multiplex platform allows syndromic diagnostic approaches for the clinical management of main human infections and resistance to antibiotics.
Coris BioConcept provides services for custom tests development and contract manufacturing. The company is present in more than 60 countries in Europe, Asia, South America, Africa and Oceania.
Coris BioConcept is continually involved in collaborative projects with Belgian and European Research Institutes, laboratories and companies for the development of breaking new solutions.
All Coris BioConcept’s products fulfil the CE marking requirements and the company is also ISO 13485 certified.
Our Quality Management System is covering “Design, development, manufacture and distribution of in vitro diagnostic tests for the detection of pathogens in the diagnosis of respiratory, gastric, enteric and parasitic diseases, the detection of resistance to antibiotics, the detection in urine of therapeutics, used for the treatment of these infectious diseases, and the distribution of instrument for electrochemical detection to be used with Coris' kit”.